These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11908868)
1. Expression of Bcl-2, Bcl-x, and Bax proteins in astrocytomas in relation to patient survival. Daido S; Tamiya T; Ono Y; Terada K; Mizumatsu S; Ohmoto T Brain Tumor Pathol; 2001; 18(2):123-9. PubMed ID: 11908868 [TBL] [Abstract][Full Text] [Related]
2. High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Tamiya T; Mizumatsu S; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T Acta Neuropathol; 2001 Apr; 101(4):334-40. PubMed ID: 11355304 [TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706 [TBL] [Abstract][Full Text] [Related]
4. bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Newcomb EW; Bhalla SK; Parrish CL; Hayes RL; Cohen H; Miller DC Acta Neuropathol; 1997 Oct; 94(4):369-75. PubMed ID: 9341939 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival. Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789 [TBL] [Abstract][Full Text] [Related]
6. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964 [TBL] [Abstract][Full Text] [Related]
8. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678 [TBL] [Abstract][Full Text] [Related]
9. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. Deininger MH; Weller M; Streffer J; Meyermann R Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558 [TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. Martin S; Toquet C; Oliver L; Cartron PF; Perrin P; Meflah K; Cuillère P; Vallette FM J Neurooncol; 2001 Apr; 52(2):129-39. PubMed ID: 11508812 [TBL] [Abstract][Full Text] [Related]
11. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer. Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490 [TBL] [Abstract][Full Text] [Related]
13. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
14. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas. Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349 [TBL] [Abstract][Full Text] [Related]
16. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814 [TBL] [Abstract][Full Text] [Related]
18. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas. Thotakura M; Tirumalasetti N; Krishna R J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753 [TBL] [Abstract][Full Text] [Related]
19. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker. Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933 [TBL] [Abstract][Full Text] [Related]
20. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Khalid H; Tsutsumi K; Yamashita H; Kishikawa M; Yasunaga A; Shibata S Cell Mol Neurobiol; 1995 Apr; 15(2):257-68. PubMed ID: 8590455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]